These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Sitbon O; Humbert M; Jagot JL; Taravella O; Fartoukh M; Parent F; Herve P; Simonneau G Eur Respir J; 1998 Aug; 12(2):265-70. PubMed ID: 9727772 [TBL] [Abstract][Full Text] [Related]
12. Effect of carbon dioxide inhalation on pulmonary hypertension induced by increased blood flow and hypoxia. Chuang IC; Yang RC; Chou SH; Huang LR; Tsai TN; Dong HP; Huang MS Kaohsiung J Med Sci; 2011 Aug; 27(8):336-43. PubMed ID: 21802645 [TBL] [Abstract][Full Text] [Related]
13. Porcine pulmonary artery and bronchial responses to endothelin-1 and norepinephrine on recovery from hypoxic pulmonary hypertension. Schindler MB; Hislop AA; Haworth SG Pediatr Res; 2006 Jul; 60(1):71-6. PubMed ID: 16690956 [TBL] [Abstract][Full Text] [Related]
14. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction. Bando M; Ishii Y; Kitamura S; Ohno S Respiration; 1998; 65(1):63-70. PubMed ID: 9523370 [TBL] [Abstract][Full Text] [Related]
15. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Rich S; Brundage BH Circulation; 1987 Jul; 76(1):135-41. PubMed ID: 2954725 [TBL] [Abstract][Full Text] [Related]
16. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats. Pozeg ZI; Michelakis ED; McMurtry MS; Thébaud B; Wu XC; Dyck JR; Hashimoto K; Wang S; Moudgil R; Harry G; Sultanian R; Koshal A; Archer SL Circulation; 2003 Apr; 107(15):2037-44. PubMed ID: 12695303 [TBL] [Abstract][Full Text] [Related]
17. Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension. Morecroft I; Murray A; Nilsen M; Gurney AM; MacLean MR Br J Pharmacol; 2009 Aug; 157(7):1241-9. PubMed ID: 19508393 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. Kennedy T; Summer W Am J Cardiol; 1982 Oct; 50(4):864-8. PubMed ID: 7124646 [TBL] [Abstract][Full Text] [Related]
19. Halothane differentially decreases 5-hydroxytryptamine-induced contractions in normal and chronic hypoxic rat pulmonary arteries. De Crescenzo V; Dubuis E; Constantin S; Rebocho M; Girardin C; Bonnet P; Vandier C Acta Physiol Scand; 2001 Nov; 173(3):247-55. PubMed ID: 11736687 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary Vasodilators and Anesthesia Considerations. Green JB; Hart B; Cornett EM; Kaye AD; Salehi A; Fox CJ Anesthesiol Clin; 2017 Jun; 35(2):221-232. PubMed ID: 28526144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]